ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
BridgeBio Stock Up 60% So Far In Dec., IPO Lockup Period Expires Today firstwordpharma
December 25, 2019Shares of BridgeBio Pharma have gone up 60% so far in December, as the clinical-stage biopharmaceutical company focused on developing medicines for genetic diseases gears up for some important events in the months ahead, reported Markets Insider.
Pharma Sources Insight January 2025
